Recent Finacing
Recent Raise
Seventh Sense Biosystems develops and manufactures the TAP painless micro-needle microfluidic blood-collection platform for capillary sampling without venipuncture, targeting point-of-care, hospital, clinical-trial, and low-resource settings.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
